Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development

被引:21
作者
Ansariniya, Hossein [1 ]
Seifati, Seyed Mohammad [2 ]
Zaker, Erfan [3 ]
Zare, Fateme [2 ,4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[2] Shahid Sadoughi Univ Med Sci, Reprod Immunol Res Ctr, Yazd, Iran
[3] Shahid Sadoughi Univ Med Sci, Fac Med, Dept Med Genet, Yazd, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran
关键词
ACUTE-RESPIRATORY-SYNDROME; NEUTRALIZING ANTIBODIES; CELL RESPONSES; CORONAVIRUS; SPIKE; EXPRESSION; PROTEINS; DISEASES; INNATE;
D O I
10.1155/2021/8870425
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus Disease 2019 (COVID-19) infections are the three epidemiological diseases caused by the Coronaviridae family. Perceiving the immune responses in these infections and the escape of viruses could help us design drugs and vaccines for confronting these infections. This review investigates the innate and adaptive immune responses reported in the infections of the three coronaviruses SARS, MERS, and COVID-19. Moreover, the present study can trigger researchers to design and develop new vaccines and drugs based on immune system responses. In conclusion, due to the need for an effective and efficient immune stimulation against coronavirus, a combination of several strategies seems necessary for developing the vaccine.
引用
收藏
页数:11
相关论文
共 89 条
[1]   The nucleoprotein is required for efficient coronavirus genome replication [J].
Almazán, F ;
Galán, C ;
Enjuanes, L .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12683-12688
[2]   MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract [J].
Alosaimi, Bandar ;
Hamed, Maaweya E. ;
Naeem, Asif ;
Alsharef, Ali A. ;
AlQahtani, Saeed Y. ;
AlDosari, Kamel M. ;
Alamri, Aref A. ;
Al-Eisa, Kholoud ;
Khojah, Taghreed ;
Assiri, Abdullah M. ;
Enani, Mushira A. .
CYTOKINE, 2020, 126
[3]   The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security [J].
Azhar, Esam I. ;
Lanini, Simone ;
Ippolito, Giuseppe ;
Zumla, Alimuddin .
EMERGING AND RE-EMERGING VIRAL INFECTIONS: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 6, 2017, 972 :49-60
[4]   Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19 [J].
Azkur, Ahmet Kursat ;
Akdis, Mubeccel ;
Azkur, Dilek ;
Sokolowska, Milena ;
van de Veen, Willem ;
Bruggen, Marie-Charlotte ;
O'Mahony, Liam ;
Gao, Yadong ;
Nadeau, Kari ;
Akdis, Cezmi A. .
ALLERGY, 2020, 75 (07) :1564-1581
[5]   SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies [J].
Barnes, Christopher O. ;
Jette, Claudia A. ;
Abernathy, Morgan E. ;
Dam, Kim-Marie A. ;
Esswein, Shannon R. ;
Gristick, Harry B. ;
Malyutin, Andrey G. ;
Sharaf, Naima G. ;
Huey-Tubman, Kathryn E. ;
Lee, Yu E. ;
Robbiani, Davide F. ;
Nussenzweig, Michel C. ;
West, Anthony P., Jr. ;
Bjorkman, Pamela J. .
NATURE, 2020, 588 (7839) :682-+
[6]   Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection [J].
Bermejo-Martin, Jesus F. ;
Almansa, Raquel ;
Menendez, Rosario ;
Mendez, Raul ;
Kelvin, David J. ;
Torres, Antoni .
JOURNAL OF INFECTION, 2020, 80 (05) :E23-E24
[7]  
Brouwer P., 2020, POTENT NEUTRALIZING
[8]  
Buchholz U, 2013, EUROSURVEILLANCE, V18, P6
[9]   Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells [J].
Cao, Yunlong ;
Su, Bin ;
Guo, Xianghua ;
Sun, Wenjie ;
Deng, Yongqiang ;
Bao, Linlin ;
Zhu, Qinyu ;
Zhang, Xu ;
Zheng, Yinghui ;
Geng, Chenyang ;
Chai, Xiaoran ;
He, Runsheng ;
Li, Xiaofeng ;
Lv, Qi ;
Zhu, Hua ;
Deng, Wei ;
Xu, Yanfeng ;
Wang, Yanjun ;
Qiao, Luxin ;
Tan, Yafang ;
Song, Liyang ;
Wang, Guopeng ;
Du, Xiaoxia ;
Gao, Ning ;
Liu, Jiangning ;
Xiao, Junyu ;
Su, Xiao-dong ;
Du, Zongmin ;
Feng, Yingmei ;
Qin, Chuan ;
Qin, Chengfeng ;
Jin, Ronghua ;
Xie, X. Sunney .
CELL, 2020, 182 (01) :73-+
[10]   Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 [J].
Catanzaro, Michele ;
Fagiani, Francesca ;
Racchi, Marco ;
Corsini, Emanuela ;
Govoni, Stefano ;
Lanni, Cristina .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)